[Problems of neurological drug therapy in pregnancy].
Piccione
E
E
Ticconi
C
C
Cennamo
M
M
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002220:Carbamazepine / Q000009:adverse effects / Q000627:therapeutic use; D002614:Chelating Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005333:Fetus / Q000187:drug effects*; D006220:Haloperidol / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D009422:Nervous System Diseases / Q000188:drug therapy*; D010634:Phenobarbital / Q000009:adverse effects / Q000627:therapeutic use; D010672:Phenytoin / Q000009:adverse effects / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D014293:Trimethadione / Q000009:adverse effects / Q000627:therapeutic use; D014635:Valproic Acid / Q000009:adverse effects / Q000627:therapeutic use
D000927:Anticonvulsants; D000978:Antiparkinson Agents; D002614:Chelating Agents; D002220:Carbamazepine; D014635:Valproic Acid; D010672:Phenytoin; D006220:Haloperidol; D014293:Trimethadione; D010634:Phenobarbital
Problemi di farmacoterapia neurologica in gravidanza.